Amgen stock increases as its new migraine treatment won FDA approval
People who experience frequent migraine headaches may soon find relief with the help of a new drug ‘Aimovig’ that won...
Other Industries
Deere & Company reports earnings of $1.20 billion for Q2
Farming equipment maker Deere & Company (DE) missed on its earnings consensus estimate for the second quarter, while revenue climbed...
FDA approves first drug to curb opioid withdrawal symptoms
Health issues associated with withdrawal symptoms during therapeutic practices involving addictive opioids have long been a challenge for medical practitioners....
Williams Co. plans $10-billion stock buyback to ease tax woes
While the recent tax overhaul came as a boon for most industries, it left some businesses in a dilemma, and...
Here’s a good reason to bet on casino and gaming stocks
The sports betting industry has never been so positive. The Supreme Court’s ruling this week lifting the ban on sports...
Zoetis expands into veterinary diagnostics arena by acquiring Abaxis
Zoetis Inc. (ZTS), a former subsidiary of Pfizer (PFE), has agreed to acquire Abaxis Inc. (ABAX) for close to $2...
Gap lands in a soup over a t-shirt and a map
Gap Inc. (GPS) had to apologize to China for depicting an incomplete map of the country on one of its...
Agilent stock plunge on weak guidance
Agilent Technologies (A) continued its year-long streak of beating analysts’ earnings estimates and followed the same for the second quarter,...
Icahn, Deason dominate as Xerox abandons Fujifilm deal
Xerox (XRX) abandoned its proposed $6.1 billion deal with Fujifilm and agreed to hand over the company’s leadership to a...
Pfizer this year: Headwinds and tailwinds
Pfizer (PFE) is an interesting stock to follow. Apart from being a great dividend stock, the company also boasts of...
Dick’s Sporting Goods and gun companies part ways
Dick’s Sporting Goods (DKS) is losing allies over its new policies. Many large gun companies decided to end their association...
Mylan’s flagship EpiPen device is in shortage in the U.S.
Mylan’s (MYL) billion dollar emergency allergy treatment injector EpiPen is now being added to the list of medications in short...
Eli Lilly acquires ARMO Biosciences; strengthens oncology portfolio
Indianapolis-based pharma giant Eli Lilly (LLY) said it would acquire late-stage immune-oncology company ARMO Biosciences (ARMO) for $1.6 billion, or...
Duke Energy posts upbeat revenue in first quarter
Duke Energy Corporation (DUK) reported operating revenues of $6.1 billion during the first quarter of 2018, up from $5.7 billion...
Boeing, General Electric to be worst hit by the nuke-deal exit
In 2015, when then-President Barack Obama agreed to lift the sanctions on Iran in return for curbs on the country’s...
Tax benefits lift Mylan’s quarterly profit
Drug maker Mylan (MYL), mainly focused on the production of generic drugs, reported yet another quarter of declining sales, a...
Plug Power revenue surges in first quarter
Plug Power Inc. (PLUG) reported revenues of $27.1 million in the first quarter of 2018, an increase of around 78%...
Disney posts upbeat Q2 results
Entertainment company Walt Disney (DIS) reported a 23% jump in earnings for the second quarter, helped by double-digit revenue growth...
‘Racist’ brands get a market beat-down, among other things
Racial profiling and incidents fueled by hate are back in the news. In the latest of incidents, Nordstrom Rack, owned...
Alibaba deepens investment in SEA by acquiring Pakistan’s e-commerce firm Daraz
Amazon’s (AMZN) top rival Alibaba (BABA) is aggressively expanding its influence in Southeast Asia. This time, the master of e-commerce...
Valeant revenue slips even as it grapples to revive its brand
Valeant Pharmaceuticals (VRX) reported total revenues of $1.99 billion for the first quarter of 2018, a decrease of 5% from...